Scott Biller

Direktor/Vorstandsmitglied bei FOGHORN THERAPEUTICS INC.

Vermögen: - $ am 30.04.2024

68 Jahre

Health Technology

Finance

Consumer Services

Aktive Positionen von Scott Biller

Unternehmen	Position	Beginn	Ende
FOGHORN THERAPEUTICS INC.	Direktor/Vorstandsmitglied	09.01.2020	-
FOGHORN THERAPEUTICS INC.	Independent Dir/Board Member	09.01.2020	-
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	01.06.2020	-
Rome Therapeutics, Inc. Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	01.02.2021	-

Unternehmen	Position	Beginn	Ende
AGIOS PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2010	31.12.2019
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01.01.2003	01.09.2010
Bristol-Myers Squibb Pharmaceutical Research Institute	Corporate Officer/Principal	01.06.2001	01.07.2003

Massachusetts Institute of Technology	Undergraduate Degree
California Institute of Technology	Doctorate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	3
Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
AGIOS PHARMACEUTICALS, INC.	Health Technology
FOGHORN THERAPEUTICS INC.	Health Technology

Private Unternehmen	4
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Commercial Services
Bristol-Myers Squibb Pharmaceutical Research Institute
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Health Technology
Rome Therapeutics, Inc. Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA.	Health Technology